npj Breast Cancer Медицинская фармакология

First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation

Po-Huang Chen, Hsin-Chung Lin, Ming-Shen Dai, Hsin-Yu Chen, Hong-Jie Jhou, Cho-Hao Lee
Springer Nature · 2026-11-07 · DOI 10.1038/s41523-026-01075-z
⬢ Цитируемость: 0 Crossref

Аннотация

npj Breast Cancer, Published online: 07 November 2026; doi:10.1038/s41523-026-01075-z First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation

Читать у издателя →